Cinical Utility of SARS-CoV-2 Antibody Testing
Guest speaker: Dr. Howard Gebel of Emory University in Atlanta, Georgia
Development for SARS-CoV-2 antibody detections tests has accelerated at an astounding pace, but many tests don’t identify the variety of antibodies that can arise in response to the virus. Dr. Howard Gebel with Emory University Hospital shares a presentation on why he and his colleagues became interested in developing a new assay that would be comprehensive, specific, and sensitive enough to build a complete antibody profile for patients exposed to the COVID-19 virus.
Please sign in to access your account. Customers must log in to access some content, recorded webinars, training materials, documents, and software.
Please provide the following to setup your user account. If you do not know your center ID, please leave the center ID field blank.
Passwords do not match